Matches in Wikidata for { <http://www.wikidata.org/entity/Q71398733> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q71398733 description "artículu científicu espublizáu en xunu de 1996" @default.
- Q71398733 description "im Juni 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71398733 description "scientific article published on 01 June 1996" @default.
- Q71398733 description "wetenschappelijk artikel" @default.
- Q71398733 description "наукова стаття, опублікована в червні 1996" @default.
- Q71398733 name "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 name "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 type Item @default.
- Q71398733 label "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 label "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 prefLabel "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 prefLabel "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 P1433 Q71398733-F70154E6-B021-454E-BC3A-312D09DDC4A8 @default.
- Q71398733 P1476 Q71398733-49661EE0-68EE-43AA-A9BC-59A32B04E2A0 @default.
- Q71398733 P2093 Q71398733-01323C9C-887E-441E-B1BB-6E1CCEFFA5AA @default.
- Q71398733 P2093 Q71398733-78AFD4D9-69EA-40FB-873B-AB415061A238 @default.
- Q71398733 P2093 Q71398733-842A03A0-EAE1-4C76-9F0C-204928AE19E4 @default.
- Q71398733 P2093 Q71398733-93AAF2FE-A35A-4E8A-B736-40AD140C2B1D @default.
- Q71398733 P2093 Q71398733-EDD5DD24-8AF8-4B96-9313-E27BDF04721A @default.
- Q71398733 P2093 Q71398733-F199A30E-B365-4031-AAC3-2539687E679B @default.
- Q71398733 P2093 Q71398733-F33AA040-DFCC-4186-90FE-300310810C8C @default.
- Q71398733 P2093 Q71398733-F7114021-086D-420E-A926-77FDF293B0AC @default.
- Q71398733 P304 Q71398733-D8FAC587-9E26-40FE-A79B-0773E13308D4 @default.
- Q71398733 P31 Q71398733-B78207CF-1D69-4055-9708-0F880706B5D7 @default.
- Q71398733 P356 Q71398733-F3060DD7-FD06-4CF6-95ED-A7C740949B3E @default.
- Q71398733 P433 Q71398733-5B03125F-0CA7-4F1D-95CF-398282D8DAD1 @default.
- Q71398733 P478 Q71398733-954AD3D0-6242-4385-8BE8-BD2470565702 @default.
- Q71398733 P577 Q71398733-8D21D4A6-A417-4D74-B5EB-9F62358E3FE3 @default.
- Q71398733 P698 Q71398733-FAB0C2F9-34C6-4FE4-A337-2BB2ED211858 @default.
- Q71398733 P921 Q71398733-1AC7B5EA-F962-41B5-A8F0-9564DA9EC70D @default.
- Q71398733 P921 Q71398733-2BD5CE94-672E-4F18-937B-7939F971F907 @default.
- Q71398733 P356 0959-8049(96)00035-4 @default.
- Q71398733 P698 8758262 @default.
- Q71398733 P1433 Q332260 @default.
- Q71398733 P1476 "Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma" @default.
- Q71398733 P2093 "A Rozenblit" @default.
- Q71398733 P2093 "B Gleissner" @default.
- Q71398733 P2093 "E D Kreuser" @default.
- Q71398733 P2093 "E Thiel" @default.
- Q71398733 P2093 "H Haynes" @default.
- Q71398733 P2093 "R Kaleya" @default.
- Q71398733 P2093 "R U Hilgenfeld" @default.
- Q71398733 P2093 "S Wadler" @default.
- Q71398733 P304 "1254-1256" @default.
- Q71398733 P31 Q13442814 @default.
- Q71398733 P356 "10.1016/0959-8049(96)00035-4" @default.
- Q71398733 P433 "7" @default.
- Q71398733 P478 "32A" @default.
- Q71398733 P577 "1996-06-01T00:00:00Z" @default.
- Q71398733 P698 "8758262" @default.
- Q71398733 P921 Q238512 @default.
- Q71398733 P921 Q42824440 @default.